Marex Group plc Announces Pricing of U.S.$500 Million Senior Notes Offering

Marex Group (Nasdaq: MRX) priced a U.S.$500 million offering of 5.680% Senior Notes due 2031 on April 16, 2026, at 100.000% of principal.

Rhea-AI Summary

Marex Group (Nasdaq: MRX) priced a U.S.$500 million offering of 5.680% Senior Notes due 2031 on April 16, 2026, at 100.000% of principal. The offering is expected to close on or about April 21, 2026, subject to customary closing conditions.

Net proceeds are to be used for working capital, funding incremental growth and other general corporate purposes; Goldman Sachs, Jefferies and J.P. Morgan are joint book‑runners.

Positive

• U.S.$500 million senior notes issued at 100.000% price
• 5.680% coupon set through market pricing
• Proceeds earmarked for working capital and growth
• Company states the issuance strengthens liquidity

Negative

• Raises $500 million of senior unsecured debt maturing in 2031
• Increases interest expense due to a 5.680% coupon
• Notes are senior unsecured, adding leverage without collateral

Argus Apr 17 session

+0.12% close to close Open Argus

Details

News Market Reaction – MRX

In the Apr 17 session, MRX gained 0.12%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement details Marex’s pricing of U.S.$500 million in 5.680% Senior Notes due 2031, issue...

Analysis

This announcement details Marex’s pricing of U.S.$500 million in 5.680% Senior Notes due 2031, issued at 100.000% of principal as senior unsecured obligations. It follows a series of shareholder-led equity offerings and strong recent results. Investors may focus on how this term debt supports working capital and incremental growth, the balance between funding flexibility and leverage, and how future updates, including Q1 2026 results, interact with the company’s evolving capital structure.

Key Figures

Senior notes size: U.S.$500 million Coupon rate: 5.680% Issue price: 100.000% +5 more

Senior notes size

U.S.$500 million

Aggregate principal amount of 5.680% Senior Notes due 2031

Coupon rate

5.680%

Interest rate on Senior Notes due 2031

Issue price

100.000%

Price to public as percentage of principal amount

Maturity year

2031

Stated maturity of the Senior Notes

Expected closing date

April 21, 2026

Anticipated settlement of the Senior Notes offering

Pre-news price change

-1.1%

Move in MRX shares prior to publication of notes pricing release

52-week range

$27.91–$53.73

MRX 52-week low and high before the debt offering news

Market cap

$3,740,724,790

Equity value of MRX before Senior Notes announcement

Previous Offering Reports

4 past events · Latest: Apr 17

Same Type 4 events

1. Apr 17

   Equity offering pricing

   24h Move

   +1.3%

   Pricing of public offering by selling shareholders at $35.50 per share.

2. Apr 14

   Equity offering launch

   24h Move

   +0.1%

   Launch of public offering of 8,500,000 shares plus 30-day option.

3. Oct 24

   Equity offering pricing

   24h Move

   +1.8%

   Pricing of shareholder offering at $24.00 per share, no proceeds to Marex.

4. Oct 21

   Equity offering launch

   24h Move

   -4.8%

   Launch of 7,000,000-share selling shareholder offering with 30-day option.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

senior notes, senior unsecured obligations, shelf registration statement, form f-3, +4 more

8 terms

senior notes financial

"announced the pricing on April 16, 2026 of a public offering ... of its 5.680% Senior Notes due 2031"

Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.

senior unsecured obligations financial

"will be senior unsecured obligations of Marex"

Senior unsecured obligations are loans or bonds that a company promises to pay back with its own money, but without any special guarantees or collateral. If the company runs into financial trouble, these debts are paid after other debts with priority, meaning they are less protected but still important. They matter because they show how risky it is to lend money to a company.

shelf registration statement regulatory

"pursuant to Marex’s existing effective shelf registration statement on Form F-3"

A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.

form f-3 regulatory

"effective shelf registration statement on Form F-3 filed with the U.S. Securities and Exchange Commission"

Form F-3 is a U.S. securities filing that lets eligible foreign companies pre-register and then quickly sell shares or other securities to raise money, because they already meet ongoing reporting and size tests. For investors it signals that the company is up-to-date with regulatory disclosure and has an efficient way to issue new securities — similar to a pre-approved credit line — which can mean faster capital raises but also potential dilution of existing holdings.

preliminary prospectus supplement regulatory

"only by means of a preliminary prospectus supplement and its accompanying base prospectus"

A preliminary prospectus supplement is an initial document that provides important details about a new stock or bond offering before it is finalized. It helps investors understand what is being sold and why, so they can decide whether to invest. Think of it as a preview before the full sales brochure is ready.

base prospectus regulatory

"by means of a preliminary prospectus supplement and its accompanying base prospectus"

A base prospectus is a detailed document that provides essential information about a financial offering, such as a bond or share issue. It acts like a comprehensive guide for investors, explaining what the investment involves, the risks involved, and how the process works. This helps investors make informed decisions before committing their money.

joint book-runners financial

"Goldman Sachs & Co. LLC, Jefferies LLC and J.P. Morgan Securities LLC are acting as Joint Book-Runners"

Joint book-runners are investment banks that share lead responsibility for organizing a securities offering, collecting and recording investor demand (the “order book”), setting the offering price, and allocating shares among buyers. Think of them as co-organizers of a ticket sale who decide how many tickets to sell, at what price, and to whom; their reputation and decisions affect how smoothly the sale goes, the final price, and early trading behavior—information investors watch closely.

u.s. securities and exchange commission regulatory

"registration statement on Form F-3 filed with the U.S. Securities and Exchange Commission (the “SEC”)"

The U.S. Securities and Exchange Commission is a government agency responsible for overseeing the stock market and protecting investors. It sets rules to ensure that companies share truthful information and that trading is fair, helping to maintain trust in the financial system. This oversight is important because it helps prevent fraud and ensures that investors can make informed decisions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Marex Group plc (Nasdaq: MRX) (“Marex”), a diversified global financial services platform, announced the pricing on April 16, 2026 of a public offering (the “Offering”) of U.S.$500 million aggregate principal amount of its 5.680% Senior Notes due 2031 (the “Notes”). The Notes will be issued at a price to the public equal to 100.000% of the principal amount thereof and will be senior unsecured obligations of Marex.

The Offering is expected to close on or about April 21, 2026, subject to the satisfaction of customary closing conditions. Marex intends to use the net proceeds from the Offering for working capital, to fund incremental growth and for other general corporate purposes.

Ian Lowitt, CEO of Marex, commented:

“This debt issuance increases our funding flexibility and further strengthens our liquidity, supporting the continued growth of our business and our ability to meet client needs. We saw a high level of investor demand, which highlights the ongoing confidence of investors in our client focused strategy, conservative capital approach and resilient liquidity profile.”

Goldman Sachs & Co. LLC, Jefferies LLC and J.P. Morgan Securities LLC are acting as Joint Book-Runners for the Offering.

The Offering is being made pursuant to Marex’s existing effective shelf registration statement on Form F-3 filed with the U.S. Securities and Exchange Commission (the “SEC”). The Offering will be made only by means of a preliminary prospectus supplement and its accompanying base prospectus. You may obtain copies of these documents for free by visiting the SEC’s website at www.sec.gov or by calling Goldman Sachs & Co. LLC toll-free at (866) 471-2526, Jefferies LLC toll-free at (877) 877-0696 or J.P. Morgan Securities LLC at (212) 834-4533.

This press release does not constitute an offer to sell or the solicitation of an offer to buy the Notes or any other security, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Forward looking statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, the expected closing date of the Offering. In some cases, these forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions.

These forward-looking statements are subject to risks, uncertainties and assumptions, some of which are beyond our control. In addition, these forward-looking statements reflect our current views with respect to future events and are not a guarantee of future performance. Actual outcomes may differ materially from the information contained in the forward-looking statements as a result of a number of factors, including, without limitation: subdued commodity market activity or pricing levels; the effects of geopolitical events, terrorism and wars, on market volatility, global macroeconomic conditions and commodity prices; our expected redomiciliaton; changes to the U.S. regulatory regime, including with respect to tariffs; changes in interest rate levels or tariffs; the risk of our clients and their related financial institutions defaulting on their obligations to us; regulatory, reputational and financial risks as a result of our international operations; software or systems failure, loss or disruption of data or data security failures; risks associated with the use of artificial intelligence; an inability to adequately hedge our positions and limitations on our ability to modify contracts and the contractual protections that may be available to us in OTC derivatives transactions; market volatility, reputational risk and regulatory uncertainty related to commodity markets, equities, fixed income, foreign exchange and cryptocurrency; the impact of climate change and the transition to a lower carbon economy on supply chains and the size of the market for certain of our energy products; the impact of changes in judgments, estimates and assumptions made by management in the application of our accounting policies on our reported financial condition and results of operations; lack of sufficient financial liquidity; if we fail to comply with applicable law and regulation, we may be subject to enforcement or other action, forced to cease providing certain services or obliged to change the scope or nature of our operations; significant costs, including adverse impacts on our business, financial condition and results of operations, and expenses associated with compliance with relevant regulations; if we fail to remediate the material weaknesses we identified in our internal control over financial reporting or prevent material weaknesses in the future, the accuracy and timing of our financial statements may be impacted, which could result in material misstatements in our financial statements or failure to meet our reporting obligations and subject us to potential delisting, regulatory investigations or civil or criminal sanctions; short seller activity and securities litigation; and other risks discussed under the caption “Risk Factors” in our preliminary prospectus supplement for the Offering and its accompanying base prospectus filed with the SEC, and our other reports filed with the SEC.

The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Enquiries please contact:

Marex:
Nicola Ratchford / Adam Strachan
+44 778 654 8889 / +1 914 200 2508   | nratchford@marex.com/ astrachan@marex.com

FTI Consulting US / UK
+1 (716) 525-7239 / +44 (0) 7976 870 961 | marex@fticonsulting.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Marex (MRX) announce about the $500 million senior notes on April 16, 2026?

Marex priced U.S.$500 million of 5.680% Senior Notes due 2031 at 100.000% price. According to Marex, the offering is expected to close on or about April 21, 2026, subject to customary closing conditions and will provide additional liquidity.

How will the MRX 5.680% notes due 2031 proceeds be used by Marex?

Proceeds will be used for working capital, incremental growth and general corporate purposes. According to Marex, the net proceeds are intended to increase funding flexibility and support business growth and client needs.

What are the key financial terms of the Marex (MRX) notes offering?

The offering is U.S.$500 million of senior unsecured notes, priced at 100.000% with a 5.680% coupon, maturing in 2031. According to Marex, joint book‑runners include Goldman Sachs, Jefferies and J.P. Morgan.

When will the Marex (MRX) senior notes offering close and what conditions apply?

The offering is expected to close on or about April 21, 2026, subject to customary closing conditions. According to Marex, closing depends on satisfaction of those standard conditions and regulatory requirements.

How might the MRX $500 million notes affect Marex’s liquidity and leverage?

The issuance is expected to strengthen Marex’s liquidity and funding flexibility in the near term. According to Marex, it adds debt capacity while supporting growth, but it also increases leverage and future interest expense.